Literature DB >> 23711562

Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity.

Bernadette M Levesque1, Leslie A Kalish, Abigail B Winston, Richard B Parad, Sonia Hernandez-Diaz, Michele Phillips, Amy Zolit, JoAnn Morey, Munish Gupta, Akiko Mammoto, Donald E Ingber, Linda J Van Marter.   

Abstract

BACKGROUND: Organ-specific vascular endothelial growth factor (VEGF) expression is decreased during the pathogenesis of bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP) several weeks before either disease can be diagnosed. Early measurement of organ-specific tissue VEGF levels might allow identification of infants at high risk for these diseases, but is not clinically feasible. Urine VEGF is easily measured and useful in early diagnosis of several diseases.
OBJECTIVES: Our aims were to assess the correlation of urine VEGF levels measured in the first postnatal month with subsequent BPD or ROP diagnosis and to determine whether various infant characteristics influence urine VEGF levels.
METHODS: 106 subjects born at <29 weeks' gestation and surviving to 36 weeks' postmenstrual age were selected from an existing database and biorepository. Urine VEGF and total protein were measured in 2-3 samples per subject.
RESULTS: Urine VEGF/protein levels increased by 72% per week (p < 0.0001) during the first postnatal month. In multivariable analysis controlling for postnatal age, lower VEGF/protein was associated with higher levels of mechanical respiratory support (p = 0.006), male gender (p = 0.001) and early sepsis (p = 0.003) but not with fraction of inspired oxygen. Lower urine VEGF/protein and mechanical ventilation were each associated with BPD and ROP. In analyses adjusted for respiratory support, lower urine VEGF/protein and ROP remained associated but urine VEGF/protein and BPD did not.
CONCLUSIONS: Low urine VEGF/protein levels in the first postnatal month are associated with mechanical ventilation, BPD, and ROP.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23711562     DOI: 10.1159/000351040

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  11 in total

1.  Vitreous Levels of Luteinizing Hormone and VEGF are Strongly Correlated in Healthy Mammalian Eyes.

Authors:  Tammy Z Movsas; Robert Sigler; Arivalagan Muthusamy
Journal:  Curr Eye Res       Date:  2018-05-03       Impact factor: 2.424

2.  Intestinal vascular endothelial growth factor is decreased in necrotizing enterocolitis.

Authors:  Animesh Sabnis; Rosa Carrasco; Shirley X L Liu; Xiaocai Yan; Elizabeth Managlia; Pauline M Chou; Xiao-Di Tan; Isabelle G De Plaen
Journal:  Neonatology       Date:  2015-01-30       Impact factor: 4.035

3.  Differences in clinical and laboratory biomarkers for short and long-term respiratory outcomes in preterm neonates.

Authors:  Richard B Parad; Janis L Breeze; Norma Terrin; Lynette K Rogers; Carolyn M Salafia; Anne Greenough; Jonathan M Davis
Journal:  Pediatr Pulmonol       Date:  2021-08-26

4.  Elimination of Signaling by the Luteinizing Hormone Receptor Reduces Ocular VEGF and Retinal Vascularization during Mouse Eye Development.

Authors:  Tammy Z Movsas; Robert Sigler; Arivalagan Muthusamy
Journal:  Curr Eye Res       Date:  2018-07-18       Impact factor: 2.424

5.  Knockdown of miR-203a-3p alleviates the development of bronchopulmonary dysplasia partly via the up-regulation of vascular endothelial growth factor A.

Authors:  Hanrong Cheng; Li Chen; Yongli Wei; Tianyong Hu; Dongcai Li; Benqing Wu
Journal:  J Bioenerg Biomembr       Date:  2021-01-07       Impact factor: 2.945

6.  Finding novel molecular connections between developmental processes and disease.

Authors:  Jisoo Park; Heather C Wick; Daniel E Kee; Keith Noto; Jill L Maron; Donna K Slonim
Journal:  PLoS Comput Biol       Date:  2014-05-29       Impact factor: 4.475

7.  Sequestration of Vascular Endothelial Growth Factor (VEGF) Induces Late Restrictive Lung Disease.

Authors:  Minna M Wieck; Ryan G Spurrier; Daniel E Levin; Salvador Garcia Mojica; Michael J Hiatt; Raghava Reddy; Xiaogang Hou; Sonia Navarro; Jooeun Lee; Amber Lundin; Barbara Driscoll; Tracy C Grikscheit
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

8.  Differentially expressed miRNAs in oxygen‑induced retinopathy newborn mouse models.

Authors:  Yunpeng Wang; Suying Wu; Yang Yang; Fen Peng; Qintao Li; Peng Tian; Erying Xiang; Honglu Liang; Beibei Wang; Xiaoyu Zhou; Hua Huang; Xiaoguang Zhou
Journal:  Mol Med Rep       Date:  2016-12-06       Impact factor: 2.952

Review 9.  A Pathogenic Relationship of Bronchopulmonary Dysplasia and Retinopathy of Prematurity? A Review of Angiogenic Mediators in Both Diseases.

Authors:  Ashley Stark; Christiane Dammann; Heber C Nielsen; MaryAnn V Volpe
Journal:  Front Pediatr       Date:  2018-06-13       Impact factor: 3.418

10.  Association of a vascular endothelial growth factor polymorphism with the development of bronchopulmonary dysplasia in Japanese premature newborns.

Authors:  Kazumichi Fujioka; Akio Shibata; Tomoyuki Yokota; Tsubasa Koda; Miwako Nagasaka; Mariko Yagi; Yasuhiro Takeshima; Hideto Yamada; Kazumoto Iijima; Ichiro Morioka
Journal:  Sci Rep       Date:  2014-03-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.